Lipner, Matthew B <br/><br/>
Irreversible JNK1-JUN inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU/FOLFOX chemotherapy.  [electronic resource] 

 -  JCI insight  04 2020 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>2379-3708 
<br/><br/><label>Standard No.: </label>10.1172/jci.insight.129905  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols<br/>Carcinoma, Pancreatic Ductal<br/>Drug Evaluation, Preclinical<br/>Drug Resistance, Neoplasm--drug effects<br/>Fluorouracil--pharmacology<br/>Humans<br/>Leucovorin<br/>MAP Kinase Kinase 4--antagonists & inhibitors<br/>Mice<br/>Mitogen-Activated Protein Kinase 8--antagonists & inhibitors<br/>Organoplatinum Compounds<br/>Pancreatic Neoplasms<br/>Xenograft Model Antitumor Assays